Capsular fragments • O-antigen and core motifs • Defined antigen research materials
BOC Sciences supports bacterial glycan synthesis for host-pathogen interaction, antibody recognition, vaccine-antigen design, and bacterial glycobiology research. Projects can address capsular polysaccharide fragments, O-antigen repeating units, LPS-related oligosaccharides, and other bacterial surface motifs. Species, strain or serotype, repeat boundaries, rare-sugar configuration, modifications, and final attachment format define the requested material.
Conceptual bacterial glycan families. The bead patterns do not assign molecular structures; species, serotype, exact repeats, modifications, and final attachment are specified in the project drawing.Project specification
Custom synthesis scope
Capsules, O-antigens, and LPS cores are different structural targets. A bacterial species name alone may not define any of them uniquely. The project uses a referenced structure and an explicit fragment drawing to distinguish a synthetic oligosaccharide from an extracted polysaccharide or a complete surface glycoconjugate.
Discuss one or more defined repeating units from a specified capsule structure. Repeat count, the bond joining successive units, and the terminal residues determine the actual fragment. O-acetylation, uronic acids, amino sugars, and other modifications are included at the positions required for the intended epitope comparison.
Plan defined O-antigen sequences or selected inner- and outer-core motifs with their own structural requirements. O-antigen, core oligosaccharide, and lipid A are distinct components. A core-fragment request does not imply inclusion of lipid A, and an O-antigen oligosaccharide does not represent the physical behavior of intact LPS.
Assess other specified bacterial carbohydrate motifs, including rare-sugar-containing or unusually linked fragments. The full drawing identifies D/L configuration, amino substitution, uronic acids, deoxy residues, and any phosphate or other noncarbohydrate group. Feasibility follows the complete structure rather than the organism label alone.
Include a defined amino, thiol, azide, or other agreed handle for a separately planned conjugation experiment. Linker length, point of attachment, and terminal state are part of the target. A conjugation-ready fragment, an isolated conjugate, and a characterized carrier-loading distribution are separate deliverables.

Target-specific route assessment
Bacterial glycans often require unusual building blocks and careful control of repeated linkages or sensitive modifications. The route review connects the natural structural reference with the deliberately selected synthetic target.
Confirm whether the source describes the requested strain or serotype and whether structural variation is reported. A finite oligosaccharide has defined ends even when the natural polymer is drawn as an infinite repeat. The project records both ends and any deliberately simplified feature.
Rare amino, deoxy, or uronic-acid residues may require dedicated precursor routes. Protecting groups and assembly order are selected around difficult configurations and branch points. O-acetylation or other sensitive groups may need late introduction or compatible deprotection conditions, depending on the target.
Longer fragments can expose additional epitopes but also increase synthetic and separation demands. A length series can test repeat-dependent recognition without assuming that the shortest repeat reproduces a polymer. The reducing end and spacer are coordinated with the intended immobilization or conjugation format.
Material and project decisions
These specification fields separate the biological source from the exact synthetic material. They also make comparison panels easier to interpret.
| Structural variable | Required specification | Why it changes the target |
|---|---|---|
| Source identity | Species, strain or serotype, and a structure reference | Different strains can display different carbohydrate epitopes |
| Surface component | Capsule, O-antigen, LPS core, or another named motif | These structures are not interchangeable parts of a single generic antigen |
| Repeat boundary | Exact first and last residues and the inter-repeat bond | Equal repeat counts can hide different terminal epitopes |
| Residue identity | D/L form, ring size, deoxy or amino substitution, and linkages | Rare-sugar configuration changes molecular recognition |
| Modification pattern | Positions and occupancy of acetyl, phosphate, or other groups | A partially modified natural population differs from one defined synthetic structure |
| Attachment format | Free reducing end, fixed derivative, or specified linker | Orientation and density can change measured recognition |
Connect the defined fragment with Glycan Conjugation Services when a carrier or immobilization format is needed. Conjugation and biological evaluation are specified in addition to the oligosaccharide synthesis itself.
Structure-to-data consistency
A bacterial glycan fragment needs evidence appropriate to its structural complexity. Composition, modification occupancy, terminal chemistry, and purity are evaluated as separate questions.
Structure
Suitable NMR and mass evidence support the rare residues, anomeric configurations, branch points, and repeat connections. A match to the expected mass cannot identify every linkage or distinguish all terminal arrangements. The agreed assignment is tied to the actual fragment drawing.
Modifications
For acetylated, phosphorylated, or otherwise modified targets, define the features requiring confirmation in the final material. Processing can alter sensitive groups, so intermediate identity alone is insufficient. A deliberately simplified analog is identified as such rather than described as a complete native structure.
Purity
Chromatography is selected for the final derivative and plausible shorter fragments, remaining precursors, or partially modified species. Additional residual-solvent, salt, or other measurements are agreed according to use. Synthetic origin alone does not establish an endotoxin result or a sterile material.
Conjugation
Characterize the final attachment group and distinguish free fragment from conjugated material. If a carrier conjugate is commissioned, loading, remaining free glycan, and the relevant distribution require a separate analytical plan. Binding or immunogenicity is not inferred from successful coupling.
Research applications
Synthetic fragments can isolate structural variables that are difficult to separate in natural polysaccharide preparations. Fragment identity and presentation determine the scope of the comparison.
Compare repeat length, terminal residues, or modification patterns in binding and inhibition experiments. Include appropriate background and presentation controls. Binding to a synthetic fragment does not alone establish recognition of a bacterial surface under physiological conditions.
Investigate specified host receptors or other binding partners with defined bacterial carbohydrate motifs. Fragment-based observations can guide mechanistic work, while full-cell interactions also depend on accessibility, density, and other surface components.
Supply defined fragments and conjugation-ready derivatives for experimental antigen design and comparison. Antigenicity, immune response, and protection are different endpoints. Synthesis of a candidate fragment does not establish vaccine efficacy or suitability for clinical manufacture.
Use assigned fragments as substrates, acceptors, or references in carbohydrate-biosynthesis and degradation studies. The enzyme, terminal state, and modifications determine whether a particular synthetic fragment is an appropriate experimental substrate.
A defined synthesis project
The project turns a biological structure into a finite, testable material specification with an agreed route and analytical package.
Project brief
Send the organism and serotype, structure reference, exact fragment drawing, modification map, length series, reducing-end format, amount, and intended recognition or conjugation experiment.

Resolve strain or serotype identity, residue names, configurations, and any reported structural uncertainty. Draw the exact synthetic fragment.

Choose fragment boundaries, repeat numbers, and modification variants. Identify the reference and any deliberate simplification in each member.

Review rare-sugar access, stereoselective coupling, branch formation, sensitive groups, and the timing of linker installation.

Prepare the agreed fragments and collect structural, purity, and final-format data suited to the selected resolution.

Provide member-specific documentation and handling information. Report separately commissioned conjugation or biological studies with their actual methods.
Project advantages
BOC Sciences organizes bacterial glycan synthesis around the exact epitope and the molecular format needed to investigate it.
The specification links the organism context and literature structure to an explicit finite fragment.
Repeat length, modification pattern, terminal residues, and attachment format are separated as experimental variables.
The reducing end and handle are chosen before synthesis so subsequent presentation requirements can be addressed in the route.
One connected glycan platform
Related insights
Explore supporting information on synthesis, characterization, and material selection for your project.
Frequently asked questions
Answers to common questions about the requested structures, characterization, and project scope.
Usually not. Supply a strain or serotype where relevant, a structural reference, and the exact fragment drawing. Repeating-unit boundaries and modifications may remain ambiguous even when the organism is known.
Yes, specified structures can be assessed individually or as a panel. Capsule, O-antigen, and LPS core motifs have different structural requirements and should be listed as separate targets.
Only if lipid A is explicitly included in the agreed structure and scope. A core or O-antigen fragment alone is not intact LPS and does not reproduce all of its physical or biological properties.
A defined handle and spacer can be assessed with the target structure. Provide the attachment position and intended carrier or surface chemistry. Conjugate preparation and loading characterization are separately scoped.
No. Any endotoxin specification needs a suitable method and agreed acceptance criterion, and clinical or manufacturing suitability requires additional requirements. These service materials support research; vaccine performance cannot be inferred from synthesis or identity data.
Define the research material your project needs
Send BOC Sciences your species or serotype reference and exact bacterial glycan targets. Include repeat boundaries, modification positions, comparison members, conjugation format, required amounts, and analytical expectations. We can assess the building blocks, assembly route, and documentation needed for your recognition or antigen research materials.
Contact BOC Sciences to discuss target-specific feasibility, specifications, and the required analytical package. Materials are intended for research use.